Rinvoq ER 45 MG tablet UU 28S
Ended Awarded
- Contract number
- SPE2DR26F9BM6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,068
Award facts
- Contract value 100% obligated
- $17,067.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,067.93 to AmerisourceBergen Drug Corp for RINVOQ ER 45 mg tablets (28-count unit of use packaging) on November 13, 2025, with completion targeted for November 14, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion blanket purchase agreement running through December 2026 that serves as the primary pharmaceutical supply vehicle for military healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills a critical role in the federal medical supply chain, particularly supporting the Defense Health Agency and military healthcare programs. The company's performance under the DLA Troop Support Medical contract demonstrates its capability to deliver a comprehensive range of pharmaceuticals and medical supplies through competitive, firm fixed-price delivery orders. This specific award for RINVOQ (baricitinib), a rheumatoid arthritis treatment, exemplifies the company's role in supplying specialty medications to support military personnel and veteran healthcare needs across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F9BM6?
SPE2DR26F9BM6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26F9BM6 worth?
The government has obligated $17,068 on SPE2DR26F9BM6.
Is contract SPE2DR26F9BM6 an order under another contract?
Yes. SPE2DR26F9BM6 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9BM6 competed?
The extent of competition for SPE2DR26F9BM6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award